Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $7.23 Million - $8.24 Million
31,036 Added 31.5%
129,568 $32.1 Million
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $3.47 Million - $4.01 Million
-14,480 Reduced 12.81%
98,532 $24.8 Billion
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $2.46 Million - $2.87 Million
10,180 Added 9.9%
113,012 $30 Billion
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $8.66 Million - $10.9 Million
36,526 Added 55.09%
102,832 $26.1 Million
Q1 2022

May 17, 2022

BUY
$257.27 - $315.76 $5.6 Million - $6.87 Million
21,760 Added 48.85%
66,306 $19.5 Million
Q4 2021

Feb 15, 2022

BUY
$292.08 - $329.01 $193,649 - $218,133
663 Added 1.51%
44,546 $14.7 Million
Q3 2021

Nov 16, 2021

SELL
$272.21 - $332.43 $8.75 Million - $10.7 Million
-32,126 Reduced 42.27%
43,883 $13.4 Million
Q2 2021

Aug 17, 2021

SELL
$225.08 - $271.69 $419,098 - $505,886
-1,862 Reduced 2.39%
76,009 $20.4 Million
Q1 2021

May 18, 2021

BUY
$212.38 - $245.9 $3.53 Million - $4.08 Million
16,604 Added 27.1%
77,871 $17.5 Million
Q4 2020

Feb 17, 2021

BUY
$212.5 - $245.46 $13 Million - $15 Million
61,267 New
61,267 $13.6 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $4.48 Million - $6.16 Million
-34,825 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $409,934 - $570,881
-3,377 Reduced 8.84%
34,825 $4.82 Million
Q4 2019

Feb 12, 2020

BUY
$133.47 - $153.48 $1.21 Million - $1.39 Million
9,074 Added 31.15%
38,202 $5.86 Million
Q3 2019

Nov 13, 2019

BUY
$135.4 - $146.47 $3.94 Million - $4.27 Million
29,128 New
29,128 $4.21 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.